<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "CCI.v1",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "sv": {
      "name": "CCI Scoring System",
      "description": "Prognostiskt instrument för patienter med terminal njursvikt"
    },
    "en": {
      "name": "CCI Scoring System",
      "description": "Prognostic tool for end stage renal disease"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-01-03",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": ""
    },
    "otherContributors": [
      "Dennis Forslund"
    ],
    "details": {
      "sv": {
        "purpose": "CCI är ett prognostiskt instrument för patienter med terminal njursvikt. Det baseras på ålder, serum-albumin och 19 andra komorbiditetsfaktorer och resulterar i en uppskattning av 1- och 2-årsöverlevnad.",
        "keywords": [
          "terminal njursvikt",
          "njursvikt",
          "CCI Scoring System",
          "albumin",
          "komorbiditetsindex",
          "Charlson Comorbidity Index"
        ],
        "use": "Den ursprungliga versionen av CCI utgick endast från 19 livshotande sjukdomstillstånd och tog inte hänsyn till ålder och serum-albumin.\n\nDen nuvarande versionen inkluderar dessa faktorer då de visat sig ha oberoende effekt på 1- och 2-årsöverlevnad hos patienter med terminal njursvikt som behandlas med dialys.\n\nTotal poäng uppgår till maximalt 45p. Ålder bidrar med 1p för varje decennium \u003e40 års ålder. Komorbiditetsfaktorerna är viktade efter deras respektive påverkan på överlevnad; tio tillstånd ger 1p, sex tillstånd ger 2p, ett tillstånd ger 3p och två tillstånd ger 6p. \n\nFör vidare information kring hur instrumentet är uppbyggt, vänligen se referens (1).",
        "misuse": "Uppskattning av överlevnadsgrad bör endast ses som understödjande information vid samtal kring beslutsfattande om huruvida dialysbehandling bör initieras eller ej.",
        "copyright": "Cambio Healthcare Systems"
      },
      "en": {
        "purpose": "The CCI is a good prognostic tool for end stage renal disease (ESRD) patients based in age, serum albumin and upto 19 other comorbid conditions to give an estimate of the 1 and 2 year survival rates. It is an easier to use tool in non-research settings.",
        "keywords": [
          "ESRD",
          "CMI",
          "Charlson Comorbidity scoring system",
          "serum albumin",
          "renal disease",
          "comorbidity"
        ],
        "use": "The CCI score originally only contained the aggregate score of the 19 comorbid conditions and did not account for age or serum albumin level. \n\nThis version includes these factors as they show an independent effect on 1 and 2-year survival rates in patients going through dialysis and ESRD. \n\nThe core score ranges from 0 to 37 and age adds a score of 1 for each decade \u003e 40 years of age for which an age of 120 yrs. (to account for outliers) produces a maximum possible score of 45.\n\nThe factors in the core score are weighted differently according to how much of a contribution they have to the survival rates. There are 10 comorbid conditions scored with 1, 6 scored with 2, 1 scored with 3 and 2 conditions scored with 6.\n\nThe serum albumin level is corrected per the lower limit of albumin (LLA) if the value is less than 3.5 g/dl using the equation to get the serum albumin factor: 3.5/LLA. \n\nThe serum albumin factor is then used to categorise the CMI results [grouped into 2-3, 4-5, 6-7 and \u003e8 scores] to generate the 1 and 2-year survival probability rates [\u003c\u003d3.5g/dl and \u003e3.5g/dl] but does not affect the CCI core score itself.\n\nMore information on deriving the probability score is shown on (1)\n",
        "misuse": "Survival estimates should only assist in cases of encouraging informed consent on the issue of starting or ending dialysis",
        "copyright": "Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "Ref. 1: Touch calc - http://touchcalc.com/calculators/cci_js#t2_probability\n\nRef. 2: Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A Simple Comorbidity Scale Predicts Clinical Outcomes and Costs in Dialysis Patients. The American Journal of Medicine 108:609-613, 2000\n\nRef. 3: Charlson ME, Pompei P, Ales KL, MacKenzie CR: A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. Journal of Chronic Diseases 40:373-383, 1987"
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "CCI.v1"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "sv": {
      "id": "sv",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "Referenser"
        }
      }
    },
    "en": {
      "id": "en",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "References"
        }
      }
    }
  }
}</script></head><body></body></html>